Biotin is vitamin B7. There is a group in France studying Biotin. They published a small study a few months ago, and a larger study was presented at the AAN meeting last month. The results of the study were reported to show a benefit in patients with primary or secondary progressive MS. There were 154 patient enrolled in this study, half on biotin and half on placebo. The outcome measured was the number of people who improved on their disability at 9 months and who continued to be improved at 12 months. 13% improved in the biotin group compared to none in the placebo group. While this is encouraging, this has to be viewed with caution. First, it is surprising that there would be improvement after only 9 months since the nervous system is very slow to heal. Also, only 13 patients improved. This low number improving suggests that the biotin was not helpful for the majority of patients, but it also brings into question whether the results could be due to difficulties with study design such as inadequate numbers of patients or problems with blinding of the treatment/placebo arms. A larger study with a phase III design will be needed to determine whether biotin is truly helpful. This would need to include outcomes such as MRI, eye examinations or evoked potentials to demonstrate that any improvement was actually due to healing of the nervous system.
Most Recent Articles
When it comes resolutions, small changes are best
A journey to a healthier you starts with baby steps. Discover how to set yourself up for success this new year and in months to come.
HPV vaccine and regular screenings can reduce cervical cancer risk
January is Cervical Health Awareness Month. Protect your health by staying current with recommended cancer screenings.
2020: The year of little sleep
This year has seen an increase in sleep issues and stress-induced insomnia. Dr. Darius Zoroufy at Swedish Sleep Medicine gives you tips to get the sleep you need.
Virtual reality adventures for people with MS
Learn about an addition to the Adventure Program offered at the Swedish Multiple Sclerosis Center that features virtual reality activities and locations.
Celebrating the holidays safely during COVID-19
Swedish shares tips and guidance from the CDC and local health officials to help you celebrate the holidays safely despite the COVID-19 pandemic.
World AIDS Day goes virtual
Virtual events and activities mark the annual observance of World AIDS Day, which focuses on learning from the past to plan for the future.
A new ride for rehabilitation
Learn how the Alinker bike will help patients have a better experience in rehabilitation for neurological conditions, age-related issues, and even COVID-19.
Hope for patients with ALS
Groundbreaking clinical trial update in the treatment and holistic care of ALS patients.
Reducing prematurity rates with equal access and care for all
The numbers of babies born too soon have steadily risen over the past few years, particularly among women of color. Access to care can help.
Is inflammation speeding up your aging process?
Long term inflammation can lead to many chronic conditions like diabetes, heart disease or arthritis, as you grow older. Find out more.
Pancreatic cancer doesn’t always show symptoms right away
Pancreatic cancer is not a common type of cancer, but it can be serious. Learn the signs, risk factors and how exercise can impact outcomes.
Understand your risk of diabetes
Diabetes is a common but serious chronic health condition. Read about your diabetes risk and how to manage your good health.
Coping with the holidays, COVID-19 and winter blues
Boost your mental wellness as we head into the holidays, winter weather and continue COVID-19 precautions with these simple tips.
SCI Spotlight: Dr. Jed Gorden, Director of Swedish Interventional Pulmonology and Medical Director for The Center of Lung Research
Caregiver Support: Emotional Wellbeing
While trying to be the perfect caregiver for your loved one, do not forget to take care of yourself as well.